ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Raymon, Mark

Follow Raymon, Mark: Website |


Barclays remains confident in St. Jude’s Medical and Durata leads

Barclays remains confident in St. Jude’s Medical and Durata leads

August 17, 2012 3:30 pm by | 0 Comments

Barclays released a report Friday maintaining its Overweight rating of St. Jude Medical (NYSE: STJ) and $48 PT. In the report, Barclays stated, "[While] we understand the concerns around Durata, ... Read more